Scholarly Index
Amir T. Fathi
Massachusetts General Hospital; 16,071 total citations; 386 total publications; best world rank #71
Massachusetts General Hospital
16,071Total citations
386Total publications
56H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 340 | US 162 | 99.03 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 319 | US 164 | 98.48 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 242 | US 117 | 98.06 |
| Histone Deacetylase Inhibitors Research | Lifetime | 258 | US 149 | 97.41 |
| Multiple Myeloma Research and Treatments | Lifetime | 678 | US 304 | 96.73 |
| Acute Lymphoblastic Leukemia research | Lifetime | 918 | US 439 | 96.96 |
| Protein Degradation and Inhibitors | Lifetime | 656 | US 322 | 95.59 |
| Acute Myeloid Leukemia Research | 2021-2025 | 71 | US 45 | 99.25 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 124 | US 65 | 97.66 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 93 | US 44 | 94.02 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 289 | US 149 | 96.01 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 195 | US 108 | 95.26 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 402 | US 208 | 93.81 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 356 | US 118 | 70.34 |